Deerfield Partners, L.P.

Insider Reports History

Entity
Company
Location
345 Park Avenue South, 12 Th Floor, New York, NY
Signature
/s/ Jonathan Isler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deerfield Partners, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Director, Director by Deputization, 10%+ Owner Class A Common Stock 650K $49.5M $76.14 Nov 3, 2022 Direct
Larimar Therapeutics, Inc. Director, Dir. by Deputization/10% Group, 10%+ Owner Common Stock 2.78M $10.4M $3.73 Sep 16, 2022 Direct

Insider Reports Filed by Deerfield Partners, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVL Nuvalent, Inc. Nov 3, 2022 0 $0 3 Nov 7, 2022 Director, Director by Deputization, 10%+ Owner
LRMR Larimar Therapeutics, Inc. Sep 16, 2022 0 $0 3 Sep 20, 2022 Director, Dir. by Deputization/10% Group, 10%+ Owner